The cell cycle inhibitory protein p21cip is not essential for maintaining β-cell cycle arrest or β-cell function in vivo

Diabetes

Volumn 55, Issue 12, 2006, Pages 3271-3278

  Cozar Castellano, Irene ^a   Haught, Marcia ^a   Stewart, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; GLUCOSE; INSULIN; PROTEIN P107; PROTEIN P130; PROTEIN P16; PROTEIN P18; PROTEIN P19; PROTEIN P27; PROTEIN P57; PROTEIN PRB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIVISION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN-SECRETING CELLS; KINETICS; MICE; MICE, KNOCKOUT;

EID: 33845530567     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0627     Document Type: Article

References (44)

1. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44:249-256, 1995
2. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA: Very slow turnover of β-cells in aged adult mice. Diabetes 54:2557-2567, 2005
3. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-Cell deficit and increased β-cell apoptosis in humans with diabetes. Diabetes 52:102-110, 2003
4. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B: β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325-1333, 2000
5. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46, 2004
6. Sorenson RL, Brelje TC: Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307, 1997
7. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M: Deletion of cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182, 2005
8. Swenne I: Glucose-stimulated DNA replication in the pancreatic islets during the development of the rat fetus. Diabetes 34:803-807, 1985
9. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor on beta cells creates and insulin secretory defects similar to that in type 2 diabetes. Cell 96:329-339, 1999
10. Garcia-Ocana A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera JC, Stewart AF: Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50:2752-2762, 2001
11. Vasavada RC, Garcia-Ocaña A, Zawalich WS, Sorenson RL, Dann PS, Ogren L, Talamantes F, Stewart AF: Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275:15399-15406, 2000
12. Drucker DJ: Glucagon-like peptide-1 and the islet β-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5148, 2003
13. Park S, Dong S, Fisher T, Dunn S, Omer AK, Weir G, White MF: Exendin-4 uses IRS-2 signaling to mediate pancreatic beta cell growth and function. J Biol Chem 281:1159-1168, 2006
14. Wang L, Fujinaka Y, Gonzalez-Pertusa JA, Vasavada RC, Garcia-Ocaña A: PKC zeta activation/expression is essential for hepatocyte growth factor (HGF)-mediated β-cell proliferation (Abstract). Diabetes 55 (Suppl. 1):A379, 2006
15. Buteau J, Foisy S, Joly E, Pretnki M: Glucagon-like peptide-1 induces pancreatic β-cell replication via transactivaton of the epidermal growth factor receptor. Diabetes 52:124-132, 2003
16. Stout LE, Svensson AM, Sorenson RL: Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 138:1592-1603, 1997
17. Fatrai S, Elghazi L, Balcazar N, Cras-Meneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E: Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55:318-325, 2006
18. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A, Vasavada RC, Stewart AF: Molecular control of cell cycle progression in the pancreatic beta cell. Endocr Rev 27:356-370, 2006
19. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534, 1999
20. Pagano M, Jackson PK: Wagging the dogma: tissue-specific cell cycle control in the mouse embryo. Cell 118:535-538, 2004
21. Georgia S, Bhushan A: Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114:963-968, 2004
22. Kushner J, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF: Cyclins D2 and D1 are essential for postnatal pancreatic beta cell growth. Mol Cell Biol 25:3752-3762, 2005
23. Friedrichsen BN, Richter HE, Hansen JA, Rhodes CJ, Nielsen JH, Billestrup N, Moldrup A: Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Mol Endocrinol 17:945-958, 2003
24. Tsutsui T, Hesabi B, Moons D, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H: Targeted disruption of cdk4 delays cell cycle entry with enhanced p27-kip activity. Mol Cell Biol 19:7011-7019, 1999
25. Rane S, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of expression of cdk4 causes insulin-deficient diabetes and cdk4 activation results in beta cell hyperplasia. Nat Genet 22:44-52, 1999
26. 1. Diabetes 53:149-159, 2004
27. cip. Diabetes 55:70-77, 2006
28. Karnick SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McClean GW, Xiong Y, Meyerson M, Kim SK: Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27kip1 and p18Ink4c. Proc Natl Acad Sci U S A 102:14659-14664, 2005
29. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y: Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20:6147-6158, 2000
30. KIP2 expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769, 2001
31. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512, 1999
32. kip cdk 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583, 1999
33. Soria G, Podhajcer O, Prives C, Gottifredi V: p21cip1/waf1 downregulation is required for efficient PCNA ubiquitinization after UV irradiation. Oncogene 25:2829-2838, 2006
34. Brugarolas J, Chandrasekaran C, Gordon JI, Beach T, Jacks T, Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557, 1995
35. Harvey M, Vogel H, Lee EY-P, Bradley A, Donehower LA: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151, 1995
36. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T: Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484, 1994
37. Vasavada RC, Stewart AF: The retinoblastoma protein, pRb, is non-essential for β-cell replication, or attainment of adult β-cell mass or function. In Program and Abstracts, 66th ADA Annual Meeting, Washington, DC, June 2006. Alexandria, VA, American Diabetes Association. In press
38. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-38, 1996
39. Zindy F, van Deursen J, Grosveld G, Sherr C, Roussel MF: INK4d-deficient mice are fertile despite testicular atrophy. Mol Cell Biol 20:372-378, 2000
40. Martins CP, Berns A: Loss of p27kip1 but not p27cip1 decreases survival and synergizes with myc in murine lymphomagenesis. EMBO J 21:3739-3748, 2002
41. Naaz A, Holsberger DR, Iwamoto GA, Nelson A, Kiyokawa H, Cooke PS: Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 18:1925-1927, 2004
42. kip2 mediates proliferative actions of PTHrP in chondrocytes. J Clin Invest 113:1334-1343, 2004
43. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T: Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424:223-227, 2003
44. Jetton T: Akting out signaling pathways in islet expansion. Oral symposium presented at the 65th Scientific Session of the American Diabetes Association, 11 June 2005, San Diego, California